We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$307M
Cap. Flow
+$50.7M
Cap. Flow %
1.97%
Top 10 Hldgs %
39.72%
Holding
426
New
36
Increased
177
Reduced
166
Closed
23
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGM icon
176
iShares Expanded Tech Sector ETF
IGM
$10B
$1.41M 0.05%
8,615
-40,454
-82% -$6.06M
GOOG icon
177
Alphabet (Google) Class C
GOOG
$4.22T
$1.39M 0.05%
3,942
+159
+4% +$56.8K
ESML icon
178
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.84B
$1.37M 0.05%
24,557
+898
+4% +$46.7K
MDYG icon
179
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.8B
$1.37M 0.05%
12,229
-33
-0.3% -$3.5K
ESGE icon
180
iShares ESG Aware MSCI EM ETF
ESGE
$6.47B
$1.37M 0.05%
25,047
-551
-2% -$28.8K
COWZ icon
181
Pacer US Cash Cows 100 ETF
COWZ
$18.3B
$1.36M 0.05%
21,838
-6,889
-24% -$435K
ALAB icon
182
Astera Labs
ALAB
$52B
$1.33M 0.05%
2,750
-3,850
-58% -$1.02M
VONV icon
183
Vanguard Russell 1000 Value ETF
VONV
$20.4B
$1.32M 0.05%
12,385
-677
-5% -$69.2K
BOTZ icon
184
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.21B
$1.3M 0.05%
+34,272
New +$1.3M
JNJ icon
185
Johnson & Johnson
JNJ
$609B
$1.3M 0.05%
5,109
+4
+0.1% +$932
VWO icon
186
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.28M 0.05%
21,406
-438
-2% -$25.7K
IEMG icon
187
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$1.27M 0.05%
15,273
+268
+2% +$21.4K
VSMV icon
188
VictoryShares US Multi-Factor Minimum Volatility ETF
VSMV
$157M
$1.26M 0.05%
21,065
-2,111
-9% -$125K
VTEB icon
189
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.6B
$1.23M 0.05%
24,312
+312
+1% +$15.7K
SUSC icon
190
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.3B
$1.17M 0.05%
50,520
+721
+1% +$16.7K
MPLX icon
191
MPLX
MPLX
$57.9B
$1.17M 0.05%
20,683
-139
-0.7% -$7.75K
HYG icon
192
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.14M 0.04%
14,312
+132
+0.9% +$10.6K
BAC icon
193
Bank of America
BAC
$430B
$1.12M 0.04%
19,684
+5,166
+36% +$275K
CGMS icon
194
Capital Group US Multi-Sector Income ETF
CGMS
$5.2B
$1.09M 0.04%
39,966
+480
+1% +$13.2K
DE icon
195
Deere & Co
DE
$161B
$1.09M 0.04%
1,714
+40
+2% +$23.2K
SPSB icon
196
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.5B
$1.08M 0.04%
36,043
-187
-0.5% -$5.61K
V icon
197
Visa
V
$682B
$1.07M 0.04%
3,130
-422
-12% -$135K
VBK icon
198
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$1.06M 0.04%
2,893
+947
+49% +$323K
SPMD icon
199
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.1B
$1.05M 0.04%
15,608
-438
-3% -$28.2K
COST icon
200
Costco
COST
$417B
$1.05M 0.04%
1,121
-16
-1% -$15.9K

Similar funds

Trilogy Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Trilogy Capital held 426 positions worth $2.58B, up 14% from $2.27B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trilogy Capital's Q2 2026 filing shows 36 new, 177 increased, 166 reduced and 23 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 21,667 shares worth $8.54M. The largest sale was State Street SPDR Portfolio Aggregate Bond ETF, an estimated $47.7M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.2% a quarter earlier, followed by Financials and Healthcare.

  • Trilogy Capital's largest Q2 2026 buy was iShares Russell 2000 Growth ETF: 21,667 shares worth $8.54M.
  • Trilogy Capital added most to ALPS Smith Core Plus Bond ETF in Q2 2026, an estimated $57.7M increase.
  • Trilogy Capital's biggest Q2 2026 reduction was State Street SPDR Portfolio Aggregate Bond ETF, cutting an estimated $47.7M.
  • Trilogy Capital fully exited Deckers Outdoor in Q2 2026, selling an estimated $3.68M.
  • Trilogy Capital's ten largest holdings make up 40% of its $2.58B portfolio in Q2 2026.
  • Trilogy Capital opened 36 new positions and closed 23 in Q2 2026.
  • Trilogy Capital's portfolio value rose 14% quarter-over-quarter to $2.58B.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.